Position in AIM
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,422
New position
Shares Held
12,222
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 16 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ground Swell Capital, LLC holds $1,358,467 across 10 Biotechnology names. AIM ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
4,320 | $411,134 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,475 | $361,035 | |
| 3 | CGON |
CG Oncology, Inc.
|
4,765 | $338,553 | |
| 4 | LNAI |
Lunai Bioworks Inc.
|
53,211 | $173,999 | |
| 5 | IVA |
Inventiva S.A.
|
12,803 | $48,395 | |
| 6 | COCP |
Cocrystal Pharma, Inc.
|
10,752 | $11,289 | |
| 7 | TOVX |
Theriva Biologics, Inc.
|
35,292 | $8,823 | |
| 8 | AIM |
AIM ImmunoTech Inc.
This page
|
12,222 | $3,422 |
All Filings in AIM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,422 | 12,222 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||